Pathstone Family Office’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $613K | Buy |
12,341
+2,914
| +31% | +$145K | ﹤0.01% | 941 |
|
|
2023
Q2 | $563K | Buy |
9,427
+519
| +6% | +$31K | 0.01% | 705 |
|
|
2023
Q1 | $503K | Sell |
8,908
-14,174
| -61% | -$801K | 0.01% | 695 |
|
|
2022
Q4 | $635K | Buy |
23,082
+1,876
| +9% | +$51.6K | 0.01% | 991 |
|
|
2022
Q3 | $1.26M | Buy |
21,206
+14,010
| +195% | +$834K | 0.01% | 631 |
|
|
2022
Q2 | $404K | Sell |
7,196
-4,817
| -40% | -$270K | 0.01% | 666 |
|
|
2022
Q1 | $885K | Buy |
+12,013
| New | +$885K | 0.02% | 358 |
|
|
2021
Q1 | – | Sell |
-12
| Closed | -$1K | – | 913 |
|
|
2020
Q4 | $1K | Hold |
12
| – | – | ﹤0.01% | 1064 |
|
|
2020
Q3 | $1K | Sell |
12
-12
| -50% | -$1K | ﹤0.01% | 738 |
|
|
2020
Q2 | $2K | Buy |
+24
| New | +$2K | ﹤0.01% | 627 |
|